Kai Eriksson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Kai Eriksson has a total of 56 co-authors. Here are the top co-authors by number of shared publications:
- Reetta Kälviäinen
Institute of Clinical Medicine, University of Eastern Finland Kuopio Finland
2 shared publications - Aiden Corvin
Neuropsychiatric Genetics Research Group, Department of Psychiatry, Trinity College Dublin, Dublin, Ireland
1 shared publication - Alice Stanton
Royal College of Surgeons in Ireland, Dublin, Ireland
1 shared publication Anna‐Leena Pirttisalo
Department of Neurology Turku University Hospital Turku Finland
1 shared publicationAnne-Mari Kantanen
Kuopio Epilepsy Center, Department of Neurology, University Hospital of Kuopio, Kuopio, Finland
1 shared publication- Anneli Kylliäinen
Faculty of Social Sciences/Psychology, Tampere University, Finland
1 shared publication
Latest Publications
- Open Access
- 11 September 2025
- Published by Elsevier in Research in Autism
- Vol. 128
Generalisability of a parent-mediated eye gaze intervention in young autistic children: An ADOS-BOSCC outcome study
- 11 September 2025
- Published by Elsevier in Research in Autism
- Vol. 128
Open AccessGeneralisability of a parent-mediated eye gaze intervention in young autistic children: An ADOS-BOSCC outcome study
- Open Access
- 27 March 2025
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 55, 97-102
Epidemiology of childhood neuromuscular diseases in two hospital districts in Finland
- 27 March 2025
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 55, 97-102
Open AccessEpidemiology of childhood neuromuscular diseases in two hospital districts in Finland
- Open Access
- 9 November 2024
- Published by Wiley in Epilepsia Open
- Vol. 10 (1) , 177-185
Epilepsy care pathway: The Finnish model
Objective: Integrated care pathways are essential for consistent, effective epilepsy care, offering equal access and quality regardless of socioeconomic status. They must align with the WHO Global Action Plan on Epilepsy, ensuring best practices and cost‐effective management. We describe the Finnish national epilepsy care pathway, which includes multiple levels of care, from initial diagnosis to long‐term care for all types of epilepsy, with a specific focus on rare and complex cases integrated with the European Reference Network (ERN) for Rare and Complex Epilepsies EpiCARE.Methods: In 2017, the Finnish government nominated Kuopio University Hospital to coordinate diagnostics and care for severe epilepsy in Finland. A national multidisciplinary consensus panel, including specialists from both adult and pediatric neurology departments across all five Finnish university hospitals and from the patient organization, was established. The resulting pathway was adopted into the current Finnish evidence‐based current care guidelines for epilepsy.Results: The Finnish epilepsy care pathway focuses on timely referrals, continuity of care and enhanced communication between healthcare providers at different levels of care. Patient involvement is assured with an individualized digital application offering secure online messaging, a seizure calendar, and remote visits. The pathway enhances virtual consultations and includes regular national diagnostic multidisciplinary meetings for severe epilepsies before selected cases are consulted in ERN EpiCARE meetings.Significance: This Finnish model for epilepsy care provides a streamlined, multidisciplinary approach to diagnosis and treatment and combines modern digital tools, data sharing, and peer support. This pathway can serve to model how integrated healthcare systems can effectively manage complex conditions.Plain Language Summary: We describe the Finnish national epilepsy care pathway, which includes multiple levels of care, from initial diagnosis to long‐term care for all types of epilepsy, with a specific focus on rare and complex cases integrated with the European Reference Network (ERN) for Rare and Complex Epilepsies EpiCARE. Finnish model for epilepsy care provides a streamlined, multidisciplinary approach to diagnosis and long‐term treatment of epilepsy. The pathway enhances virtual consultations and includes national and European‐level diagnostic multidisciplinary meetings for severe epilepsies. To improve outcomes, we emphasize the use of modern digital tools, data sharing, and peer support.
- 9 November 2024
- Published by Wiley in Epilepsia Open
- Vol. 10 (1) , 177-185
Open AccessEpilepsy care pathway: The Finnish model
Objective: Integrated care pathways are essential for consistent, effective epilepsy care, offering equal access and quality regardless of socioeconomic status. They must align with the WHO Global Action Plan on Epilepsy, ensuring best practices and cost‐effective management. We describe the Finnish national epilepsy care pathway, which includes multiple levels of care, from initial diagnosis to long‐term care for all types of epilepsy, with a specific focus on rare and complex cases integrated with the European Reference Network (ERN) for Rare and Complex Epilepsies EpiCARE.Methods: In 2017, the Finnish government nominated Kuopio University Hospital to coordinate diagnostics and care for severe epilepsy in Finland. A national multidisciplinary consensus panel, including specialists from both adult and pediatric neurology departments across all five Finnish university hospitals and from the patient organization, was established. The resulting pathway was adopted into the current Finnish evidence‐based current care guidelines for epilepsy.Results: The Finnish epilepsy care pathway focuses on timely referrals, continuity of care and enhanced communication between healthcare providers at different levels of care. Patient involvement is assured with an individualized digital application offering secure online messaging, a seizure calendar, and remote visits. The pathway enhances virtual consultations and includes regular national diagnostic multidisciplinary meetings for severe epilepsies before selected cases are consulted in ERN EpiCARE meetings.Significance: This Finnish model for epilepsy care provides a streamlined, multidisciplinary approach to diagnosis and treatment and combines modern digital tools, data sharing, and peer support. This pathway can serve to model how integrated healthcare systems can effectively manage complex conditions.Plain Language Summary: We describe the Finnish national epilepsy care pathway, which includes multiple levels of care, from initial diagnosis to long‐term care for all types of epilepsy, with a specific focus on rare and complex cases integrated with the European Reference Network (ERN) for Rare and Complex Epilepsies EpiCARE. Finnish model for epilepsy care provides a streamlined, multidisciplinary approach to diagnosis and long‐term treatment of epilepsy. The pathway enhances virtual consultations and includes national and European‐level diagnostic multidisciplinary meetings for severe epilepsies. To improve outcomes, we emphasize the use of modern digital tools, data sharing, and peer support.
- Open Access
- 24 August 2024
- Published by Elsevier in Epilepsy & Behavior
- Vol. 159, 109988
Education and employment among patients with childhood-onset epilepsy in adulthood: A population-based cohort study
- 24 August 2024
- Published by Elsevier in Epilepsy & Behavior
- Vol. 159, 109988
Open AccessEducation and employment among patients with childhood-onset epilepsy in adulthood: A population-based cohort study
- Open Access
- 31 October 2007
- Published by Springer Nature in European Journal of Human Genetics
- Vol. 16 (2) , 176-183
An assessment of the Irish population for large-scale genetic mapping studies involving epilepsy and other complex diseases
The recent completion of the International HapMap Project has rapidly advanced our understanding of linkage disequilibrium (LD) in the human genome. Today, tagging SNPs (tSNPs) can be quickly and easily selected and consequently HapMap data are regularly applied to both small- and large-scale genetic mapping studies. However, to correctly interpret the application of HapMap-derived tSNPs in a genetic mapping study, an understanding of how well HapMap data represents LD in the study population is critical. The Irish population had not previously been characterised in this way. Here, we do so using a set of 4424 SNPs selected from 279 candidate genes for epilepsy genotyped across 1118 healthy individuals from the Irish, British, Finnish and Australian populations. By considering the Irish population alongside surrounding European populations, our results confirm that the HapMap European-derived population accurately estimates patterning of LD in European descent populations. The Irish population appears notably well matched to the European HapMap population, and is markedly similar to the neighbouring British population. Although we were unable to detect significant substructure within the Irish population (a favourable result for genetic mapping), methods for controlling stratification should always be incorporated. This analysis therefore confirms that the genetic architecture of the Irish population is well suited to the study of complex traits and that tSNPs selected using the HapMap data can be confidently applied to the Irish population.
- 31 October 2007
- Published by Springer Nature in European Journal of Human Genetics
- Vol. 16 (2) , 176-183
Open AccessAn assessment of the Irish population for large-scale genetic mapping studies involving epilepsy and other complex diseases
The recent completion of the International HapMap Project has rapidly advanced our understanding of linkage disequilibrium (LD) in the human genome. Today, tagging SNPs (tSNPs) can be quickly and easily selected and consequently HapMap data are regularly applied to both small- and large-scale genetic mapping studies. However, to correctly interpret the application of HapMap-derived tSNPs in a genetic mapping study, an understanding of how well HapMap data represents LD in the study population is critical. The Irish population had not previously been characterised in this way. Here, we do so using a set of 4424 SNPs selected from 279 candidate genes for epilepsy genotyped across 1118 healthy individuals from the Irish, British, Finnish and Australian populations. By considering the Irish population alongside surrounding European populations, our results confirm that the HapMap European-derived population accurately estimates patterning of LD in European descent populations. The Irish population appears notably well matched to the European HapMap population, and is markedly similar to the neighbouring British population. Although we were unable to detect significant substructure within the Irish population (a favourable result for genetic mapping), methods for controlling stratification should always be incorporated. This analysis therefore confirms that the genetic architecture of the Irish population is well suited to the study of complex traits and that tSNPs selected using the HapMap data can be confidently applied to the Irish population.